CORS Conference 2020
Pandemics as driver for regulatory innovation
- regulatory changes in times of disaster
The regulatory world is currently under immense pressure, with global expectations to approve the long-awaited cure against COVID-19 as fast as possible. At the same time as the regulatory system is pushed to the limit, it innovates and instigates changes to accommodate fast patient access to treatment. In this year’s conference, we will focus on how pandemics foster regulatory innovation. Themes to be addressed include the use of novel data techniques, such as artificial intelligence to be applied in regulatory decision-making, as well as communication of uncertainties and benefit/risk evaluation of medicines.
How have these been used in time of regulatory pressure? What can we learn from the exceptional circumstances? And what regulatory innovations should we take forward?
- Kristoffer Albris, Assistant Professor, Department of Anthropology, University of Copenhagen
- Andrea Julsing Keyter, Senior Manager for medical devices and radiation control, South African Health Products Regulatory Authority
- Frederic Bouder, Professor, Department of Safety, Economics and Planning, University of Stavanger
- Jesper Kjaer, Head of Data Analytics Centre, Danish Medicines Agency
- John Zibert, Chief Medical Officer, LEO Innovation Lab
- Niels Buch Leander, Global Head of Regulatory Affairs and Safety, NNIT A/S.
- François Houÿez, Director of Information & Access to Treatments, EURORDIS
- Juan García Burgos, Head of Public and Stakeholders Engagement Department, European Medicines Agency
- Andy Powrie-Smith, Executive Director Communications and Partnerships, EFPIA
The Conference took place online.
CORS invited stakeholders from all backgrounds, academia, industry, and regulatory agencies.